ID: ALA3415251

Max Phase: Preclinical

Molecular Formula: C13H12ClN3S2

Molecular Weight: 309.85

Molecule Type: Small molecule

Representations

Canonical SMILES:  Clc1ccc2sc(SCCCn3ccnc3)nc2c1

Standard InChI:  InChI=1S/C13H12ClN3S2/c14-10-2-3-12-11(8-10)16-13(19-12)18-7-1-5-17-6-4-15-9-17/h2-4,6,8-9H,1,5,7H2

Standard InChI Key:  VYMAWDPQDMCRQX-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 309.85

Molecular Weight (Monoisotopic): 309.0161

AlogP: 4.33

#Rotatable Bonds: 5

Polar Surface Area: 30.71

Molecular Species: NEUTRAL

HBA: 5

HBD: 0

#RO5 Violations: 0

HBA (Lipinski): 3

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 6.53

CX LogP: 3.89

CX LogD: 3.85

Aromatic Rings: 3

Heavy Atoms: 19

QED Weighted: 0.52

Np Likeness Score: -2.81

References

1. Salerno L, Pittalà V, Romeo G, Modica MN, Marrazzo A, Siracusa MA, Sorrenti V, Di Giacomo C, Vanella L, Parayath NN, Greish K..  (2015)  Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.,  96  [PMID:25874340] [10.1016/j.ejmech.2015.04.003]

Source

Source(1):

• Scientific Literature